Dachaigh › Ailse sgamhain cealla bheag › Illinois › Chicago
Sgrùdaidhean clionaigeach Ailse sgamhain cealla bheag ann an Chicago, IL
Tha 13 sgrùdaidhean airson Ailse sgamhain cealla bheag a’ lorg phàirtichean aig làraichean ann agus timcheall air Chicago (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
A’ fastadhÌre 1
- The University of Chicago, Chicago
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
A’ fastadhÌre 3
- University of Chicago Medical Center /ID# 280149, Chicago
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
A’ fastadhÌre 1
- Northwestern University Feinberg School of Medicine, Chicago
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
A’ fastadhÌre 1/2
- University of Chicago ( Site 1108), Chicago
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
A’ fastadhÌre 2
- Northwestern, Chicago
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
A’ fastadhÌre 3
- Rush MD Anderson Cancer Center, Chicago
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
A’ fastadhÌre 1
- University of Illinois Chicago, Chicago
Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
A’ fastadhÌre 2
- University of Illinois Chicago, Chicago
A Study of LY4175408 in Participants With Advanced Cancer
A’ fastadhÌre 1
- The University of Chicago Medical Center (UCMC), Chicago
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
A’ fastadhÌre 2
- University of Illinois Cancer Center, Chicago
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
A’ fastadhÌre 2
- Northwestern University, Chicago
Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
A’ fastadhÌre 1/2
- Jesse Brown VA Medical Center, Chicago, IL, Chicago
Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)
A’ fastadhÌre 2
- University of Chicago Medicine, Chicago
Sgrùdaidhean Ailse sgamhain cealla bheag ann am bailtean eile
- Houston, TX26 sgrùdaidhean
- Arlington, VA23 sgrùdaidhean
- New York City, NY22 sgrùdaidhean
- Boston, MA21 sgrùdaidhean
- Nashville, TN20 sgrùdaidhean
- Los Angeles, CA20 sgrùdaidhean
- Orlando, FL15 sgrùdaidhean
- Dallas, TX13 sgrùdaidhean
- Cleveland, OH13 sgrùdaidhean
- St. Louis, MO13 sgrùdaidhean
- Detroit, MI12 sgrùdaidhean
- Washington, DC12 sgrùdaidhean
Sgrùdaidhean eile ann an Chicago
- Aillse Sgamhain Neo-chealla-beag61 sgrùdaidhean
- Aillse a' bhroilleach59 sgrùdaidhean
- Aillse (gach seòrsa)51 sgrùdaidhean
- Ailse metastatach45 sgrùdaidhean
- Aillse Prostata45 sgrùdaidhean
- Ailseachadh nan Sgamhan41 sgrùdaidhean
- Obesity41 sgrùdaidhean
- Cancer Ovarian36 sgrùdaidhean
- Aillse colorectal34 sgrùdaidhean
- Buailteach34 sgrùdaidhean
- Fàilligeadh a' Chridhe31 sgrùdaidhean
- Ro-throm29 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.